LINDSEY SENCI: Open Payments
NPI 1649771544 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 18 payments from 5 companies in 2025. Trend: 2023 $240 · 2024 $477 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $179 |
| Novo Nordisk Inc | 8 | $157 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Exact Sciences Corporation | 1 | $14 |
Products named: QULIPTA, Wegovy, Rybelsus, Auvelity, VRAYLAR, FARXIGA, Ozempic, AIRSUPRA.
Industry payments across IL — which companies pay providers there.
